Skip to content

Evaluation of the effect of cannabidiol in the treatment of dystonia

Evaluation of the effect of cannabidiol in the treatment of adult dystonias-a randomized placebo-controlled clinical trial

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20211019052811N1
Enrollment
60
Registered
2021-11-27
Start date
2021-11-22
Completion date
Unknown
Last updated
2021-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

dystonia. Dystonia

Interventions

Intervention 1: Intervention group:Liposomal cannabidiol drops are given at a dose of 10 mg every 6 hours. The drug is started with a dose of 10 mg every 12 hours (2 ml) and after 5 days is increased

Sponsors

Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with focal-generalized dystonia Failure to improve the patient's dystonic symptoms with previous drug treatments

Exclusion criteria

Exclusion criteria: Evidence that dystonia is secondary to other diseases History of liver disease Pregnancy or intent to conceive or breastfeed History of dystonic surgery, including deep brain stimulation and destructive surgery

Design outcomes

Primary

MeasureTime frame
Intensity of dystonia motion symptoms based on Van Marsden Scale and Global Dystonia Scale and TWSTRS. Timepoint: Before the intervention (0), then 3, 6, and 9 weeks after the start of the intervention or placebo. Method of measurement: Van Marsden Scale and Global Dystonia Scale and TWSTRS.

Secondary

MeasureTime frame
Quality of life using SF-36 questionnaire. Timepoint: Before the intervention (0), then 3, 6, and 9 weeks after the start of the intervention or placebo. Method of measurement: SF-36 questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactOlfati Nahid

Mashhad University of Medical Sciences

olfatin@mums.ac.ir+98 51 3859 6778

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026